Michael Ambrogi

2019

In 2019, Michael Ambrogi earned a total compensation of $4.7M as Chief Operating Officer at NovoCure, a 79% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$257,400
Option Awards$3,245,466
Salary$390,000
Stock Awards$769,998
Other$13,400
Total$4,676,264

Ambrogi received $3.2M in option awards, accounting for 69% of the total pay in 2019.

Ambrogi also received $257.4K in non-equity incentive plan, $390K in salary, $770K in stock awards and $13.4K in other compensation.

Rankings

In 2019, Michael Ambrogi's compensation ranked 2,412th out of 13,971 executives tracked by ExecPay. In other words, Ambrogi earned more than 82.7% of executives.

ClassificationRankingPercentile
All
2,412
out of 13,971
83rd
Division
Manufacturing
872
out of 5,692
85th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
115
out of 832
86th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
60
out of 535
89th
Industry
Surgical and Medical Instruments and Apparatus
37
out of 350
89th
Source: SEC filing on April 27, 2020.

Ambrogi's colleagues

We found four more compensation records of executives who worked with Michael Ambrogi at NovoCure in 2019.

2019

William Doyle

NovoCure

Chairman

2019

Asaf Danziger

NovoCure

Chief Executive Officer

2019

Wilhelmus Groenhuysen

NovoCure

Chief Financial Officer

2019

Pritesh Shah

NovoCure

Chief Commercial Officer

News

In-depth

You may also like